Thrombospondin type I domain containing 7A (THSD7A) mediates endothelial cell migration and tube formation

Journal of Cellular Physiology

Volumn 222, Issue 3, 2010, Pages 685-694

  Wang, Chieh Huei ^a   Su, Pei Tsu ^a   Du, Xiao Yan ^b   Kuo, Meng Wei ^a   Lin, Chia Yi ^a   Yang, Chung Chi ^a,c   Chan, Hau Shien ^a   Chang, Shing Jyh ^a   Kuo, Calvin ^b   Seo, Kyunga ^b   Leung, Lawrence L ^b   Chuang, Yung Jen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TAOYUAN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; PAXILLIN; PLACENTA PROTEIN; THROMBOSPONDIN; THROMBOSPONDIN TYPE I DOMAIN CONTAINING 7A; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL CELL; ANTIANGIOGENIC THERAPY; ARTICLE; ASSAY; CARBOXY TERMINAL SEQUENCE; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; DATA MINING; ENDOTHELIUM CELL; FOCAL ADHESION; GENE EXPRESSION; GENE IDENTIFICATION; GENE LIBRARY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SERIAL ANALYSIS OF GENE EXPRESSION; UMBILICAL ARTERY; UMBILICAL VEIN;

ACTINS; AMINO ACID SEQUENCE; CELL MOVEMENT; CELLS, CULTURED; CYTOSKELETON; DATA MINING; ENDOTHELIAL CELLS; FOCAL ADHESIONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LIBRARY; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAVBETA3; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PAXILLIN; THROMBOSPONDINS; TRANSFECTION; UMBILICAL ARTERIES; UMBILICAL VEINS;

EID: 73649085461     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21990     Document Type: Article

References (47)

1. Adams JC. 2001. Thrombospondins: Multifunctional regulators of cell interactions. Annu Rev Cell Dev Biol 17:25-51.
2. Avraham HK, Lee TH, Koh Y, Kim TA, Jiang S, Sussman M, Samarel AM, Avraham S. 2003. Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase. J Biol Chem 278:36661-36668.
3. Berrier AL, Yamada KM. 2007. Cell-matrix adhesion. J Cell Physiol 213:565-573.
4. Boguski MS, Schuler GD. 1995. ESTablishing a human transcriptmap.Nat Genet 10:369-371.
5. Brooks PC, Clark RA, Cheresh DA. 1994. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569-571.
6. Brown MC, Turner CE. 2004. Paxillin: Adapting to change. Physiol Rev 84:1315-1339.
7. Byzova TV, Goldman CK, Pampori N, Thomas KA, Bett A, Shattil SJ, Plow EF. 2000. Amechanism for modulation of cellular responses to VEGF:Activation of the integrins. Mol Cell 6:851-860.
8. Cao Y. 2009. Tumor angiogenesis and molecular targets for therapy. Front Biosci 14:3962-3973.
9. Chen JJ, Rowley JD, Wang SM. 2000. Generation of longer cDNA fragments from serial analysis of gene expression tags for gene identification. Proc Natl Acad Sci USA 97:349-353.
10. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS,Wang Z, Rockson SG, van de Rijn M, Botstein D, Brown PO. 2003. Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA 100:10623-10628.
11. Conway EM, Carmeliet P. 2004. The diversity of endothelial cells: A challenge for therapeutic angiogenesis. Genome Biol 5:207.
12. Dawson DW, Pearce SF, Zhong R, Silverstein RL, Frazier WA, Bouck NP. 1997. CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells. J Cell Biol 138:707-717.
13. Deakin NO, Turner CE. 2008. Paxillin comes of age. J Cell Sci 121:2435-2444.
14. Gao B, Saba TM, Tsan MF. 2002. Role of alpha(v)beta(3)-integrin in TNF-alpha-induced endothelial cell migration. Am J Physiol Cell Physiol 283:C1196-C1205.
15. Hodivala-Dilke K. 2008. alphavbeta3 integrin and angiogenesis:Amoody integrin in a changing environment. Curr Opin Cell Biol 20:514-519.
16. Hodivala-Dilke KM, Reynolds AR, Reynolds LE. 2003. Integrins in angiogenesis: Multitalented molecules in a balancing act. Cell Tissue Res 314:131-144.
17. Hynes RO. 1992. Integrins: Versatility,modulation, and signaling in cell adhesion. Cell 69:11-25.
18. Iruela-Arispe ML, Lombardo M, Krutzsch HC, Lawler J, Roberts DD. 1999. Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats. Circulation 100:1423-1431.
19. Jaffe EA, Nachman RL, Becker CG, Minick CR. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. JClin Invest 52:2745-2756.
20. Kabir-Salmani M, Shiokawa S, Akimoto Y, Sakai K, Nagamatsu S, Nakamura Y, Lotfi A, Kawakami H, Iwashita M. 2003. Alphavbeta3 integrin signaling pathway is involved in insulin-like growth factor I-stimulated human extravillous trophoblast cell migration. Endocrinology 144:1620-1630.
21. Katz BZ, Zamir E, Bershadsky A, Kam Z, Yamada KM, Geiger B. 2000. Physical state of the extracellular matrix regulates the structure and molecular composition of cell-matrix adhesions. Mol Biol Cell 11:1047-1060.
22. Kondo A, Hashimoto S, Yano H,Nagayama K,Mazaki Y, Sabe H. 2000. A new paxillin-binding protein, PAG3/Papalpha/KIAA0400, bearing an ADP-ribosylation factor GTPase-activating protein activity, is involved in paxillin recruitment to focal adhesions and cell migration. Mol Biol Cell 11:1315-1327.
23. Lamalice L, Le Boeuf F, Huot J. 2007. Endothelial cell migration during angiogenesis. Circ Res 100:782-794.
24. Lash AE, Tolstoshev CM, Wagner L, Schuler GD, Strausberg RL, Riggins GJ, Altschul SF. 2000. SAGEmap: A public gene expression resource. Genome Res 10:1051-1060.
25. Lee YH, Kayyali US, Sousa AM, Rajan T, Lechleider RJ, Day RM. 2007. Transforming growth factor-beta1 effects on endothelial monolayer permeability involve focal adhesion kinase/ Src. Am J Respir Cell Mol Biol 37:485-493.
26. Ludbrook SB, Barry ST, Delves CJ, Horgan CM. 2003. The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3. Biochem J 369:311-318.
27. May JA, Ratan H, Glenn JR, Losche W, Spangenberg P, Heptinstall S. 1998. GPIIb-IIIa antagonists cause rapid disaggregation of platelets pre-treated with cytochalasin D. Evidence that the stability of platelet aggregates depends on normal cytoskeletal assembly. Platelets 9:227-232.
28. Moissoglu K, Schwartz MA. 2006. Integrin signalling in directed cell migration. Biol Cell 98:547-555.
29. Nakayama M,Kikuno R, Ohara O. 2002. Protein-protein interactions between large proteins: Two-hybrid screening using a functionally classified library composed of long cDNAs. Genome Res 12:1773-1784.
30. Norman JC, Jones D, Barry ST, Holt MR, Cockcroft S, Critchley DR. 1998. ARF1 mediates paxillin recruitment to focal adhesions and potentiates Rho-stimulated stress fiber formation in intact and permeabilized Swiss 3T3 fibroblasts. J Cell Biol 143:1981-1995.
31. Novak JP, Sladek R, Hudson TJ. 2002. Characterization of variability in large-scale gene expression data: Implications for study design. Genomics 79:104-113.
32. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. 1997. A model for p53-induced apoptosis. Nature 389:300-305.
33. Reynolds LE,Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM. 2002. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med 8:27-34.
34. Sipes JM,Krutzsch HC, Lawler J, Roberts DD. 1999. Cooperation between thrombospondin-1 type 1 repeat peptides and alpha(v)beta(3) integrin ligands to promote melanoma cell spreading and focal adhesion kinase phosphorylation. J Biol Chem 274:22755-22762.
35. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW. 2000. Genes expressed in human tumor endothelium. Science 289:1197-1202.
36. Swerlick RA, Lee KH, Wick TM, Lawley TJ. 1992. Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 148:78-83.
37. Taverna D, Crowley D, Connolly M, Bronson RT, Hynes RO. 2005. A direct test of potential roles for beta3 and beta5 integrins in growth and metastasis of murine mammary carcinomas. Cancer Res 65:10324-10329.
38. Thierry-Mieg D, Thierry-Mieg J. 2006. AceView: A comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7:11-14.
39. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N. 1993. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122:497-511.
40. Turner CE, West KA, Brown MC. 2001. Paxillin-ARF GAP signaling and the cytoskeleton. Curr Opin Cell Biol 13:593-599.
41. Uchida H, Kondo A, Yoshimura Y, Mazaki Y, Sabe H. 2001. PAG3/Papalpha/KIAA0400, a GTPase-activating protein for ADP-ribosylation factor (ARF), regulates ARF6 in Fcgamma receptor-mediated phagocytosis of macrophages. J Exp Med 193:955-966.
42. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. 1995. Serial analysis of gene expression. Science 270:484-487.
43. West KA, Zhang H, Brown MC, Nikolopoulos SN, Riedy MC, Horwitz AF, Turner CE. 2001. The LD4 motif of paxillin regulates cell spreading and motility through an interaction with paxillin kinase linker (PKL). J Cell Biol 154:161-176.
44. Young GD, Murphy-Ullrich JE. 2004. The tryptophan-richmotifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex. J Biol Chem 279:47633-47642.
45. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B. 1999. Identification and classification of p53-regulated genes. Proc Natl Acad Sci USA 96:14517-14522.
46. Zhang X, Lawler J. 2007. Thrombospondin-based antiangiogenic therapy. Microvasc Res 74:90-99.
47. Zhang P, Wang H, Min X,Wang Y, Tang J, Cheng J, Li D, Chen X, Cheng F, Wang N, Yang H. 2009. Pim-3 is expressed in endothelial cells and promotes vascular tube formation. J Cell Physiol 220:82-90.